Showing results (81-90 of 121) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.Cancer|September 15, 1987
Primary radiation therapy for locally advanced breast cancerT Sheldon, D F Hayes, B Cady, et al.Urology|February 2, 2000
Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinomaW K Oh, J Manola, A A Renshaw, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancerA J Nixon, D Neuberg, D F Hayes, et al.Breast Cancer Research and Treatment|July 19, 2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcomeP Miller, K M Kidwell, D Thomas, et al.Cancer Chemotherapy and Pharmacology|January 29, 1999
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancerK A Havlin, M J Ramirez, C M Legler, et al.Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.Cancer Research|April 6, 2001
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B studyR A Bok, S Halabi, D T Fei, et al.International Journal of Radiation Oncology, Biology, Physics|September 7, 1999
Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancerP H Hardenbergh, A Recht, S Gollamudi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.Pageof 13